文献速递心力衰竭与心肌病冠心病

心导管监护病房中SCAI心源性休克分级的死亡风险预测

Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.
PubMed 文献 · J Am Coll Cardiol · 2019-09-20

该研究回顾性分析Mayo Clinic心脏重症监护病房(CICU)2007至2015年收治的10,004例患者,按SCAI A至E期对心源性休克(CS)分级。随SCAI分期升高,院内死亡率逐步上升;多变量校正后各期死亡风险均高于A期,心脏骤停(CA)亦独立增加死亡风险,且在急性冠脉综合征或心衰亚组中结果一致。

要点

  • 入院时SCAI A至E期可对CICU患者进行稳健的院内死亡风险分层。
  • SCAI分期越高,院内死亡率越高,E期未校正死亡率为67.0%。
  • 合并心脏骤停者死亡风险独立升高,应将CA纳入风险评估。

核心结论

  • 在CICU入院时评估的SCAI心源性休克分级(含是否合并心脏骤停)可提供稳健的院内死亡风险分层,可作为临床与 research 工具用于识别、沟通和预测CS及CS高危患者的死亡风险。

研究设计与样本

  • 回顾性分析Mayo Clinic CICU于2007至2015年收治的患者,共10,004例独特患者。
  • 依据CICU入院时是否存在低血压或心动过速、低灌注、恶化及难治性休克,回顾性划分SCAI CS A至E期,并按是否合并心脏骤停分层分析院内死亡率。

主要发现

  • SCAI A至E期患者占比分别为46.0%、30.0%、15.7%、7.3%和1.0%。
  • 各期未校正院内死亡率分别为3.0%、7.1%、12.4%、40.4%和67.0%(p < 0.001)。
  • 多变量校正后,与A期相比各更高SCAI分期的院内死亡风险升高(校正比值比1.53至6.80;均p < 0.001)。
  • 心脏骤停亦与院内死亡风险升高相关(校正比值比3.99;95%CI 3.27至4.86;p < 0.001)。
  • 在急性冠脉综合征或心力衰竭亚组中结果一致。

关键数值与推荐

  • SCAI CS分期依据低血压或心动过速、低灌注、恶化、难治性休克进行划分。
  • 研究人群中43.1%为急性冠脉综合征,46.1%为心力衰竭,12.1%合并心脏骤停。

临床怎么用

  • 可在CICU入院时采用SCAI A至E期分级评估心源性休克及高危患者的院内死亡风险。
  • 评估时应同时记录是否合并心脏骤停,以完善风险沟通与分层管理。

局限性

  • 为单中心回顾性研究,SCAI分期为回顾性划分,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A new 5-stage cardiogenic shock (CS) classification scheme was recently proposed by the Society for Cardiovascular Angiography and Intervention (SCAI) for the purpose of risk stratification. OBJECTIVES: This study sought to apply the SCAI shock classification in a cardiac intensive care unit (CICU) population. METHODS: The study retrospectively analyzed Mayo Clinic CICU patients admitted between 2007 and 2015. SCAI CS stages A through E were classified retrospectively using CICU admission data based on the presence of hypotension or tachycardia, hypoperfusion, deterioration, and refractory shock. Hospital mortality in each SCAI shock stage was stratified by cardiac arrest (CA). RESULTS: Among the 10,004 unique patients, 43.1% had acute coronary syndrome, 46.1% had heart failure, and 12.1% had CA. The proportion of patients in SCAI CS stages A through E was 46.0%, 30.0%, 15.7%, 7.3%, and 1.0% and unadjusted hospital mortality in these stages was 3.0%, 7.1%, 12.4%, 40.4%, and 67.0% (p < 0.001), respectively. After multivariable adjustment, each higher SCAI shock stage was associated with increased hospital mortality (adjusted odds ratio: 1.53 to 6.80; all p < 0.001) compared with SCAI shock stage A, as was CA (adjusted odds ratio: 3.99; 95% confidence interval: 3.27 to 4.86; p < 0.001). Results were consistent in the subset of patients with acute coronary syndrome or heart failure. CONCLUSIONS: When assessed at the time of CICU admission, the SCAI CS classification, including presence or absence of CA, provided robust hospital mortality risk stratification. This classification system could be implemented as a clinical and research tool to identify, communicate, and predict the risk of death in patients with, and at risk for, CS.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Jentzer JC, van Diepen S, Barsness GW, et al. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2019. PMID: 31548097. doi:10.1016/j.jacc.2019.07.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。